FI944047A0 - Koostumuksia, jotka sisältävät ranitidiini/vismuttikarboksylaattisuoloja - Google Patents
Koostumuksia, jotka sisältävät ranitidiini/vismuttikarboksylaattisuolojaInfo
- Publication number
- FI944047A0 FI944047A0 FI944047A FI944047A FI944047A0 FI 944047 A0 FI944047 A0 FI 944047A0 FI 944047 A FI944047 A FI 944047A FI 944047 A FI944047 A FI 944047A FI 944047 A0 FI944047 A0 FI 944047A0
- Authority
- FI
- Finland
- Prior art keywords
- compositions containing
- carboxylate salts
- bismuth carboxylate
- containing ranitidine
- ranitidine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/245—Bismuth; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB909019875A GB9019875D0 (en) | 1990-09-11 | 1990-09-11 | Pharmaceutical compositions |
NO920408A NO179694C (no) | 1990-09-11 | 1992-01-30 | Farmasöytiske preparater inneholdende ranitidinderivater |
PCT/EP1992/000498 WO1993017679A1 (en) | 1990-09-11 | 1992-03-05 | Compositions containing ranitidine/bismuth carboxylates salts |
Publications (2)
Publication Number | Publication Date |
---|---|
FI944047A0 true FI944047A0 (fi) | 1994-09-02 |
FI944047A FI944047A (fi) | 1994-09-02 |
Family
ID=47884627
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI944047A FI944047A (fi) | 1990-09-11 | 1994-09-02 | Koostumuksia, jotka sisältävät ranitidiini/vismuttikarboksylaattisuoloja |
Country Status (33)
Country | Link |
---|---|
US (1) | US5456925A (fi) |
EP (1) | EP0558779B1 (fi) |
JP (1) | JPH0692849A (fi) |
KR (1) | KR100196308B1 (fi) |
AT (2) | AT405134B (fi) |
AU (2) | AU640816B2 (fi) |
BE (1) | BE1005115A5 (fi) |
BG (1) | BG61931B1 (fi) |
CA (1) | CA2050970C (fi) |
CH (1) | CH683068A5 (fi) |
CY (1) | CY1988A (fi) |
DE (2) | DE4130061A1 (fi) |
DK (1) | DK159191A (fi) |
ES (1) | ES2072647T3 (fi) |
FI (1) | FI944047A (fi) |
FR (1) | FR2666508B1 (fi) |
GB (2) | GB9019875D0 (fi) |
HK (1) | HK60894A (fi) |
HU (1) | HU211846A9 (fi) |
IE (1) | IE65049B1 (fi) |
IL (1) | IL99428A (fi) |
IT (1) | IT1249696B (fi) |
MX (1) | MX9101009A (fi) |
NL (1) | NL194907C (fi) |
NO (1) | NO179694C (fi) |
NZ (1) | NZ239731A (fi) |
OA (1) | OA10093A (fi) |
RO (1) | RO112084B1 (fi) |
RU (1) | RU2108097C1 (fi) |
SE (1) | SE509694C2 (fi) |
SK (1) | SK279591B6 (fi) |
WO (1) | WO1993017679A1 (fi) |
ZA (1) | ZA917176B (fi) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9019875D0 (en) * | 1990-09-11 | 1990-10-24 | Glaxo Group Ltd | Pharmaceutical compositions |
GB9120131D0 (en) * | 1991-09-20 | 1991-11-06 | Glaxo Group Ltd | Medicaments |
DE69228738D1 (de) * | 1991-12-06 | 1999-04-29 | Glaxo Group Ltd | Zusammensetzungen zur Behandlung von entzündlichen Zuständen oder Analgesie, die Ranitidin Wismuth Citrat und einen NSAID enthalten |
GB9127150D0 (en) * | 1991-12-20 | 1992-02-19 | Smithkline Beecham Plc | Novel treatment |
GB9501560D0 (en) | 1995-01-26 | 1995-03-15 | Nycomed Imaging As | Contrast agents |
US6117412A (en) * | 1995-01-26 | 2000-09-12 | Nycomed Imaging As | Non-cluster type bismuth compounds |
WO2000010562A1 (fr) * | 1998-08-18 | 2000-03-02 | Leonidov Nikolai B | Forme physiquement stable et amorphe aux rayons x de ranitidine d'hydrochlorure ayant une action anti-ulcere accrue, et procede de production |
EP1104673A1 (en) * | 1999-11-30 | 2001-06-06 | Bayer Classics | A hydrogen carbonate-containing, desintegrating agent-free pharmaceutical composition |
KR100412290B1 (ko) * | 2001-11-27 | 2003-12-31 | 주식회사 동구제약 | 라니티딘 함유 현탁제 조성물 및 그의 제조방법 |
US20060100271A1 (en) * | 2004-11-08 | 2006-05-11 | Keith Whitehead | Stabilized aqueous ranitidine compositions |
US9629809B2 (en) | 2008-07-21 | 2017-04-25 | Si Group, Inc. | High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms |
WO2010011522A1 (en) * | 2008-07-21 | 2010-01-28 | Albemarle Corporation | High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms |
CN115697354A (zh) * | 2020-06-01 | 2023-02-03 | 香港大学 | 用于治疗sars-cov-2感染的组合物和方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4608257A (en) * | 1984-01-03 | 1986-08-26 | Board Of Regents For Oklahoma State University | Composition and method for treating heat stress |
GB8629781D0 (en) * | 1986-12-12 | 1987-01-21 | Glaxo Group Ltd | Pharmaceutical compositions |
EP0282132B1 (en) * | 1987-03-09 | 1992-09-30 | The Procter & Gamble Company | Compositions and their use for treating gastrointestinal disorders |
DE3710462A1 (de) * | 1987-03-30 | 1988-10-13 | Heumann Pharma Gmbh & Co | Pharmazeutische zubereitung zur behandlung von erkrankungen des magen-darm-traktes |
FR2633181B1 (fr) * | 1988-06-24 | 1992-01-10 | Glaxo Lab Sa | Composition pharmaceutique a base de ranitidine et son procede de preparation |
CH679582A5 (fi) * | 1988-07-18 | 1992-03-13 | Glaxo Group Ltd | |
ES2040307T3 (es) * | 1988-10-08 | 1993-10-16 | Dr. R. Pfleger Chemische Fabrik Gmbh | Procedimiento para producir un preparado medicamentoso liquido que contiene bismuto. |
AU641903B2 (en) * | 1988-10-26 | 1993-10-07 | Glaxo Group Limited | Carboxylic acid derivatives |
US5013560A (en) * | 1989-03-17 | 1991-05-07 | The Procter & Gamble Company | Microbially-stable bismuth-containing liquid pharmaceutical suspensions |
GB9019875D0 (en) * | 1990-09-11 | 1990-10-24 | Glaxo Group Ltd | Pharmaceutical compositions |
-
1990
- 1990-09-11 GB GB909019875A patent/GB9019875D0/en active Pending
-
1991
- 1991-09-06 IL IL9942891A patent/IL99428A/en not_active IP Right Cessation
- 1991-09-09 CA CA002050970A patent/CA2050970C/en not_active Expired - Fee Related
- 1991-09-10 SE SE9102604A patent/SE509694C2/sv not_active IP Right Cessation
- 1991-09-10 CH CH2655/91A patent/CH683068A5/fr not_active IP Right Cessation
- 1991-09-10 ZA ZA917176A patent/ZA917176B/xx unknown
- 1991-09-10 FR FR9111146A patent/FR2666508B1/fr not_active Expired - Fee Related
- 1991-09-10 JP JP3230571A patent/JPH0692849A/ja active Pending
- 1991-09-10 IT ITRM910673A patent/IT1249696B/it active IP Right Grant
- 1991-09-10 DE DE4130061A patent/DE4130061A1/de not_active Withdrawn
- 1991-09-10 NL NL9101533A patent/NL194907C/nl not_active IP Right Cessation
- 1991-09-10 KR KR1019910015760A patent/KR100196308B1/ko not_active IP Right Cessation
- 1991-09-10 BE BE9100841A patent/BE1005115A5/fr not_active IP Right Cessation
- 1991-09-10 AU AU83757/91A patent/AU640816B2/en not_active Ceased
- 1991-09-10 IE IE319191A patent/IE65049B1/en not_active IP Right Cessation
- 1991-09-10 AT AT0180191A patent/AT405134B/de not_active IP Right Cessation
- 1991-09-10 GB GB9119284A patent/GB2248185B/en not_active Expired - Fee Related
- 1991-09-10 NZ NZ239731A patent/NZ239731A/en unknown
- 1991-09-10 DK DK159191A patent/DK159191A/da not_active Application Discontinuation
-
1992
- 1992-01-30 NO NO920408A patent/NO179694C/no not_active IP Right Cessation
- 1992-03-05 RO RO94-01459A patent/RO112084B1/ro unknown
- 1992-03-05 SK SK1060-94A patent/SK279591B6/sk unknown
- 1992-03-05 AU AU13347/92A patent/AU1334792A/en not_active Abandoned
- 1992-03-05 EP EP92103741A patent/EP0558779B1/en not_active Expired - Lifetime
- 1992-03-05 ES ES92103741T patent/ES2072647T3/es not_active Expired - Lifetime
- 1992-03-05 RU RU94040869A patent/RU2108097C1/ru active
- 1992-03-05 DE DE69202696T patent/DE69202696D1/de not_active Expired - Lifetime
- 1992-03-05 MX MX9101009A patent/MX9101009A/es unknown
- 1992-03-05 AT AT92103741T patent/ATE122883T1/de not_active IP Right Cessation
- 1992-03-05 WO PCT/EP1992/000498 patent/WO1993017679A1/en active IP Right Grant
-
1994
- 1994-03-22 US US08/215,658 patent/US5456925A/en not_active Expired - Lifetime
- 1994-06-23 HK HK60894A patent/HK60894A/xx not_active IP Right Cessation
- 1994-08-12 OA OA60553A patent/OA10093A/en unknown
- 1994-09-01 BG BG99021A patent/BG61931B1/bg unknown
- 1994-09-02 FI FI944047A patent/FI944047A/fi unknown
-
1995
- 1995-06-28 HU HU95P/P00511P patent/HU211846A9/hu unknown
-
1997
- 1997-09-05 CY CY198897A patent/CY1988A/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI944047A (fi) | Koostumuksia, jotka sisältävät ranitidiini/vismuttikarboksylaattisuoloja | |
DE59010810D1 (de) | Arzneimittel enthaltend als Wirkstoff R-alpha-Liponsäure oder S-alpha-Liponsäure | |
TR22827A (tr) | N-(4-fenoksi-2,6-diizopropilfenil)-n'-ters,butil tio,uerenin beyaz sineklerle muecadelede kullanilmasi | |
DK0431877T3 (da) | Cimetidinholdige farmaceutiske midler | |
SE8902288L (sv) | Farmaceutisk komposition | |
NO308393B1 (no) | Antibakterielt munnhygienepreparat | |
SE8702941L (sv) | Farmaceutisk, n-acetyl-cysteininnehallande, vattenloslig komposition | |
RU93058306A (ru) | Моногидрат l-тартрата(-)-(s)-2,8-диметил-3-метилен-1-окса-8-азаспиро-(4,5)-декана | |
FI791565A (fi) | Farmaceutiska sammansaettningar innehaollande prostaglandinfoereningar | |
DK197089A (da) | Laegemidler indeholdende pentamidin | |
DK179786D0 (da) | (-)-1beta-ethyl-1alfa-hydroxylmethyl-1,2,3,4,6,7,12,12balfa-octa-hydroindolo(2,3-a)quinolizin og syreadditionssalte deraf, deres fremstilling og anvendelse som farmaceutika | |
DE3869156D1 (de) | Fungizide 2-anilinthiazoline. | |
DK420187A (da) | Oxiran-pseudooligosaccharider, deres fremstilling og anvendelse | |
ATE78402T1 (de) | Waesserige loesungen von doxorubicin. | |
AR247561A1 (es) | Procedimiento para la preparacion de una sal formada por ranitidina y un complejo de bismuto con un acido carboxilico o un solvato de dicha sal | |
FR2191842A2 (en) | Insecticidal compsns contg thiapyrans - 4-(4'-methyl-3'-hexenyl) 5,6-dihydro-2-H-thiapyran and its 5-oxide have juvenile hormone activity | |
SE8605216D0 (sv) | Novel medicinal use |